Skip to main navigation Skip to search Skip to main content

Reply: Competing risk and surveillance thresholds for HCC in patients with PSC

  • Magnus Holmer*
  • , Michael Ingre
  • , Martti Färkkilä
  • , Cyriel Ponsioen
  • , Bregje Mol
  • , Christoph Schramm
  • , Trine Folseraas
  • , Kristine Wiencke
  • , Nora Cazzagon
  • , Elisa Catanzaro
  • , Antonio Molinaro
  • , Emma Nilsson
  • , Johan Vessby
  • , Stergios Kechagias
  • , Nils Nyhlin
  • , M. rten Werner
  • , Annika Bergquist
  • *Corresponding author for this work
  • Karolinska Institutet
  • Helsinki University Hospital
  • Amsterdam UMC
  • University of Hamburg
  • University of Oslo
  • University of Padua
  • University of Gothenburg
  • Lund University
  • Uppsala University
  • Linköping University
  • Örebro University
  • Umeå University

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
JournalHepatology
VolumePublish Ahead of Print
DOIs
Publication statusPublished - 2025

Cite this